241 related articles for article (PubMed ID: 15585416)
21. mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members.
Chada S; Mhashilkar AM; Liu Y; Nishikawa T; Bocangel D; Zheng M; Vorburger SA; Pataer A; Swisher SG; Ramesh R; Kawase K; Meyn RE; Hunt KK
Cancer Gene Ther; 2006 May; 13(5):490-502. PubMed ID: 16282987
[TBL] [Abstract][Full Text] [Related]
22. [Effect of adenovirus-mediated mda-7/IL-24 gene infection on apoptosis of drug-resistant human ovarian cancer cell lines OVCAR-3 and OVCAR-8/TR].
Xiong J; Peng ZL; Tan X; Yan NH
Ai Zheng; 2007 Apr; 26(4):371-6. PubMed ID: 17430654
[TBL] [Abstract][Full Text] [Related]
23. Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer.
Walther W; Siegel R; Kobelt D; Knösel T; Dietel M; Bembenek A; Aumann J; Schleef M; Baier R; Stein U; Schlag PM
Clin Cancer Res; 2008 Nov; 14(22):7545-53. PubMed ID: 19010873
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors.
Li HL; Li S; Shao JY; Lin XB; Cao Y; Jiang WQ; Liu RY; Zhao P; Zhu XF; Zeng MS; Guan ZZ; Huang W
Gene Ther; 2008 Feb; 15(4):247-56. PubMed ID: 18097470
[TBL] [Abstract][Full Text] [Related]
25. INGN-241. Introgen.
Gopalkrishnan R
Curr Opin Investig Drugs; 2002 Dec; 3(12):1773-7. PubMed ID: 12528316
[TBL] [Abstract][Full Text] [Related]
26. A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.
Small EJ; Carducci MA; Burke JM; Rodriguez R; Fong L; van Ummersen L; Yu DC; Aimi J; Ando D; Working P; Kirn D; Wilding G
Mol Ther; 2006 Jul; 14(1):107-17. PubMed ID: 16690359
[TBL] [Abstract][Full Text] [Related]
27. Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells.
Lebedeva IV; Su ZZ; Emdad L; Kolomeyer A; Sarkar D; Kitada S; Waxman S; Reed JC; Fisher PB
Oncogene; 2007 Feb; 26(5):733-44. PubMed ID: 16924242
[TBL] [Abstract][Full Text] [Related]
28. Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer.
Yoo GH; Hung MC; Lopez-Berestein G; LaFollette S; Ensley JF; Carey M; Batson E; Reynolds TC; Murray JL
Clin Cancer Res; 2001 May; 7(5):1237-45. PubMed ID: 11350889
[TBL] [Abstract][Full Text] [Related]
29. Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.
Palmer DH; Mautner V; Mirza D; Oliff S; Gerritsen W; van der Sijp JR; Hubscher S; Reynolds G; Bonney S; Rajaratnam R; Hull D; Horne M; Ellis J; Mountain A; Hill S; Harris PA; Searle PF; Young LS; James ND; Kerr DJ
J Clin Oncol; 2004 May; 22(9):1546-52. PubMed ID: 15051757
[TBL] [Abstract][Full Text] [Related]
30. [Effects of adenoviral-mediated melanoma differentiation associated gene-7/IL-24 on growth and apoptosis of breast cancer cells].
Ni QC; Yang L; Zhang CH; Zhou F; Zhu HJ; Huang JF
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):3008-11. PubMed ID: 19080082
[TBL] [Abstract][Full Text] [Related]
31. MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
Chada S; Sutton RB; Ekmekcioglu S; Ellerhorst J; Mumm JB; Leitner WW; Yang HY; Sahin AA; Hunt KK; Fuson KL; Poìndexter N; Roth JA; Ramesh R; Grimm EA; Mhashilkar AM
Int Immunopharmacol; 2004 May; 4(5):649-67. PubMed ID: 15120650
[TBL] [Abstract][Full Text] [Related]
32. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
Atencio IA; Grace M; Bordens R; Fritz M; Horowitz JA; Hutchins B; Indelicato S; Jacobs S; Kolz K; Maneval D; Musco ML; Shinoda J; Venook A; Wen S; Warren R
Cancer Gene Ther; 2006 Feb; 13(2):169-81. PubMed ID: 16082381
[TBL] [Abstract][Full Text] [Related]
33. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.
Senzer N; Mani S; Rosemurgy A; Nemunaitis J; Cunningham C; Guha C; Bayol N; Gillen M; Chu K; Rasmussen C; Rasmussen H; Kufe D; Weichselbaum R; Hanna N
J Clin Oncol; 2004 Feb; 22(4):592-601. PubMed ID: 14726502
[TBL] [Abstract][Full Text] [Related]
34. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
35. TNFerade, an adenovector carrying the transgene for human tumor necrosis factor alpha, for patients with advanced solid tumors: surgical experience and long-term follow-up.
McLoughlin JM; McCarty TM; Cunningham C; Clark V; Senzer N; Nemunaitis J; Kuhn JA
Ann Surg Oncol; 2005 Oct; 12(10):825-30. PubMed ID: 16132372
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
Nishikawa T; Ramesh R; Munshi A; Chada S; Meyn RE
Mol Ther; 2004 Jun; 9(6):818-28. PubMed ID: 15194048
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia.
Zhang S; Li Y; Li L; Zhang Y; Gao N; Zhang Z; Zhao H
J Oral Maxillofac Surg; 2009 May; 67(5):1074-82. PubMed ID: 19375021
[TBL] [Abstract][Full Text] [Related]
38. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions.
Rini BI; Selk LM; Vogelzang NJ
Clin Cancer Res; 1999 Oct; 5(10):2766-72. PubMed ID: 10537340
[TBL] [Abstract][Full Text] [Related]
39. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells.
Su Z; Emdad L; Sauane M; Lebedeva IV; Sarkar D; Gupta P; James CD; Randolph A; Valerie K; Walter MR; Dent P; Fisher PB
Oncogene; 2005 Nov; 24(51):7552-66. PubMed ID: 16044151
[TBL] [Abstract][Full Text] [Related]
40. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
